Rectal cancer
Conditions
Interventions
Experimental Group:Buccal needle treatment
control group:no
Sponsors
Cancer Hospital Affiliated to Shandong First Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: From December 30 2024 to December 30 2025 patients of both sexes aged =75 years with body mass index of 18.5-25.0 kg/m2 of American Society of Anesthesiologists physical status II or III scheduled for elective laparoscopic radical resection of rectal cancer were enrolled. Informed consent was signed.
Exclusion criteria
Exclusion criteria: Facial paralysis acute head and face injury soft tissue disease or infection; Mental illness hearing or language impairment; Severe organ dysfunction (such as heart liver kidney brain etc.); Diseases of the nervous system blood system or immune system; Combined with other tumors; Allergy to narcotic drugs; Opioid abuse long-term use of analgesics or history of alcohol dependence; Abnormal coagulation or long-term use of anticoagulants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Influence of perioperative immune function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative Complications;Influence of perioperative immune function;Patient PAIN score; | — |
Countries
China
Contacts
Public ContactXiangzhen Min
Cancer Hospital Affiliated to Shandong First Medical University
Outcome results
None listed